ANAPTYSBIO, INC. (ANAB) Revenue 2017–2026
ANAPTYSBIO, INC. (ANAB) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$234.6MFY2026 · since FY2017: $16.7M → $234.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $234.6M | +157.0% |
| FY2025 | $91.3M | +432.0% |
| FY2024 | $17.2M | +66.8% |
| FY2023 | $10.3M | -83.7% |
| FY2022 | $63.2M | -15.8% |
| FY2021 | $75.0M | +837.5% |
| FY2020 | $8.0M | +60.0% |
| FY2019 | $5.0M | -50.0% |
| FY2018 | $10.0M | -40.1% |
| FY2017 | $16.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ANAB financial trends
ANAB Net incomeANAB Net marginANAB Gross profitANAB Gross marginANAB Operating incomeANAB Operating marginANAB Operating cash flowANAB Free cash flowANAB Capital expendituresANAB Return on equityANAB Stock buybacksANAB Dividends paidANAB Total assetsANAB Total liabilitiesANAB Shareholders’ equityANAB overview →